An ED-Based Smoking Cessation Intervention Is Feasible, Effective
THURSDAY, March 28, 2024 (HealthDay News) — A brief opportunistic intervention to support...
Read More
Pharmacy
Rise in Drug-Resistant Gonorrhea in China May Pose Global Threat
THURSDAY, March 28, 2024 (HealthDay News) — Cases of a strain of highly antibiotic-resistant...
Read More
SCOTUS Appears Skeptical of Arguments to Curb Abortion Pill Access
WEDNESDAY, March 27, 2024 (HealthDay News) — Following oral arguments presented on Tuesday,...
Read More
Simple Risk Score Predicts Severe Cisplatin-Linked Acute Kidney Injury
WEDNESDAY, March 27, 2024 (HealthDay News) — A simple risk score consisting of nine...
Read More
Patients Interested in Learning About Preeclampsia Risk
WEDNESDAY, March 27, 2024 (HealthDay News) — The majority of childbearing-age people would...
Read More
Minocycline Does Not Decrease Geographic Atrophy Enlargement in AMD
MONDAY, March 25, 2024 (HealthDay News) — Oral minocycline is not associated with a decrease...
Read More
FDA Approves Oral Duvyzat for Duchenne Muscular Dystrophy
MONDAY, March 25, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read More
Eli Lilly Reports Temporary Shortage of Humalog and Insulin Lispro Injection
MONDAY, March 25, 2024 (HealthDay News) — Eli Lilly & Co. announced on Friday a...
Read More
Considerable Number of Abortion Seekers Accessed Services After Dobbs
MONDAY, March 25, 2024 (HealthDay News) — Despite implementation of state-level bans and...
Read More
CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma
THURSDAY, March 21, 2024 (HealthDay News) — For patients with recurrent glioblastoma,...
Read More
One in Five State Medicaid Programs Cover Antiobesity Medications
THURSDAY, March 21, 2024 (HealthDay News) — As of early 2023, one in five state Medicaid...
Read More
SGLT2i, GLP-1 RA Prescribing Lower for Minority Patients
WEDNESDAY, March 20, 2024 (HealthDay News) — Pharmacy dispensing patterns for sodium-glucose...
Read More
Second Primary Malignancies Represent Small Proportion of Adverse Events After CAR T-Cell Therapy
WEDNESDAY, March 20, 2024 (HealthDay News) — Second primary malignancies (SPMs) represent a...
Read More
U.S. Abortion Rates Rose After Dobbs Decision, Led by Medication Abortions
TUESDAY, March 19, 2024 (HealthDay News) — Following the historic reversal of Roe v. Wade in...
Read More
Iptacopan Improves Hematologic, Clinical Outcomes in Persistent Anemia
TUESDAY, March 19, 2024 (HealthDay News) — The first-in-class oral factor B inhibitor...
Read More
AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in Alopecia
TUESDAY, March 19, 2024 (HealthDay News) — For adults with alopecia areata, continuous...
Read More
AANA Issues Considerations for GLP-1 Receptor Agonist Use Before Surgery
TUESDAY, March 19, 2024 (HealthDay News) — Considerations for anesthesia care in relation to...
Read More
CDC, AMA Urge Americans to Make Sure They Are Vaccinated Against Measles
TUESDAY, March 19, 2024 (HealthDay News) — As measles cases rise globally, the U.S. Centers...
Read More
AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia
MONDAY, March 18, 2024 (HealthDay News) — Continuous treatment with baricitinib in...
Read More
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
MONDAY, March 18, 2024 (HealthDay News) — Lebrikizumab demonstrates improvement in skin...
Read More